SEC Form 4 · accession 0001209191-18-010146
VERTEX PHARMACEUTICALS INC / MA · VRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Amit Sachdev
Officer — EVP, CRO
Period of report
Feb 12, 2018
Accepted (ET)
Feb 14, 2018 · 6:23 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000875320
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Feb 12, 2018 | S | 4,500 | $149.22 | D | 59,958 | D | |
| Common StockF3,F4 | Feb 12, 2018 | S | 3,200 | $150.44 | D | 56,758 | D | |
| Common StockF3,F5 | Feb 12, 2018 | S | 7,296 | $151.22 | D | 49,462 | D | |
| Common StockF3,F6 | Feb 12, 2018 | S | 1,100 | $152.26 | D | 48,362 | D | |
| Common StockF3,F7 | Feb 12, 2018 | S | 1,400 | $153.25 | D | 46,962 | D | |
| Common StockF3,F8 | Feb 12, 2018 | S | 300 | $153.92 | D | 46,662 | D | |
| Common Stock | holding | — | — | — | 882 | I | 401(k) | |
| Common Stock | holding | — | — | — | 12,215 | I | Held in Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Transaction made pursuant to Mr. Sachdev's company-approved trading plan under Rule 10b5-1.
- F2Open market sales reported on this line occurred at a weighted average price of $149.22 (range $148.77 to $149.75).
- F3Mr. Sachdev undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- F4Open market sales reported on this line occurred at a weighted average price of $150.44 (range $149.81 to $150.76).
- F5Open market sales reported on this line occurred at a weighted average price of $151.22 (range $150.81 to $151.79).
- F6Open market sales reported on this line occurred at a weighted average price of $152.26 (range $151.83 to $152.81).
- F7Open market sales reported on this line occurred at a weighted average price of $153.25 (range $152.87 to $153.82).
- F8Open market sales reported on this line occurred at a weighted average price of $153.92 (range $153.89 to $153.99).